Medtronic PLC
DUS:2M6

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
DUS:2M6
Watchlist
Price: 74.87 EUR -2.22% Market Closed
Market Cap: 99.6B EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+21%
Revenue
Forecast
+5%
Operating Income
Forecast
+17%
Net Income
Forecast
+30%

Wall Street
Price Targets

2M6 Price Targets Summary
Medtronic PLC

Wall Street analysts forecast 2M6 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2M6 is 86.33 EUR with a low forecast of 75.64 EUR and a high forecast of 104.05 EUR.

2M6 Lowest Forecast
Wall Street Target
75.64 EUR
1% Upside
2M6 Average Forecast
Wall Street Target
86.33 EUR
15% Upside
2M6 Highest Forecast
Wall Street Target
104.05 EUR
39% Upside
Lowest
Price Target
75.64 EUR
1% Upside
Average
Price Target
86.33 EUR
15% Upside
Highest
Price Target
104.05 EUR
39% Upside
Medtronic PLC Competitors:
Price Targets
SRT
Sartorius AG
63% Upside
PODD
Insulet Corp
0% Upside
M
MYO
Myomo Inc
193% Upside
NVCR
Novocure Ltd
89% Upside
SRT
Sartorius AG
63% Upside
PODD
Insulet Corp
0% Upside
M
MYO
Myomo Inc
193% Upside
NVCR
Novocure Ltd
89% Upside
ANGO
AngioDynamics Inc
67% Upside
STIM
Neuronetics Inc
74% Upside
A
688617
APT Medical Inc
18% Upside
EMBLA
Embla Medical hf
8% Upside

Revenue
Forecast

Revenue Estimate
Medtronic PLC

For the last 8 years the compound annual growth rate for Medtronic PLC's revenue is 1%. The projected CAGR for the next 4 years is 5%.

1%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medtronic PLC

For the last 8 years the compound annual growth rate for Medtronic PLC's operating income is 0%. The projected CAGR for the next 4 years is 15%.

0%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medtronic PLC

For the last 8 years the compound annual growth rate for Medtronic PLC's net income is 0%. The projected CAGR for the next 4 years is 24%.

0%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-36%
Average Miss
What are analyst estimates?

See Also

Summary
2M6 intrinsic value, competitors valuation, and company profile.
DCF Valuation
2M6 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
2M6 stock valuation using valuation multiples.
Wall Street Estimates
2M6 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
2M6 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 2M6's stock price target?
Price Target
86.33 EUR

According to Wall Street analysts, the average 1-year price target for 2M6 is 86.33 EUR with a low forecast of 75.64 EUR and a high forecast of 104.05 EUR.

What is Medtronic PLC's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Medtronic PLC's revenue is 1%. The projected CAGR for the next 4 years is 5%.

What is Medtronic PLC's Operating Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Medtronic PLC's operating income is 0%. The projected CAGR for the next 4 years is 15%.

What is Medtronic PLC's Net Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Medtronic PLC's net income is 0%. The projected CAGR for the next 4 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.